Agenus to participate at 5th annual evercore isi healthconx conference

Lexington, mass., nov. 16, 2022 (globe newswire) -- agenus (nasdaq: agen), an immuno-oncology company with a broad pipeline targeting cancer and infectious disease, today announced that dr. garo armen, chairman and ceo of agenus, and dr. steven o'day, chief medical officer, will participate in a virtual fireside chat at the 5th annual evercore isi healthconx conference on wednesday, november 30th at 12:35pm et. the conference will be held virtually from november 29th – december 1st, during which agenus will host one-on-one meetings with investors.
AGEN Ratings Summary
AGEN Quant Ranking